Skip to main content
. 2021 Oct 18;40(Suppl 1):91–102. doi: 10.1007/s40273-021-01092-9

Table 2.

Patient characteristics as described by caregivers (for pediatric patients) or by adult patient themselves and caregiver characteristics

Patient characteristics Adult patient survey
(N = 84)
Caregiver survey (proxy-reported)
(N = 83)
Age (years), mean (SD) 33.9 (11.5) 8.4 (3.4)
Age at diagnosis (years), mean (SD) 3.27 (6.32) 0.95 (0.35)
Age at first symptoms (years), mean (SD) 1.43 (1.34) 0.78 (0.35)
Gender (male), n (%) 23 (27) 75 (90)
Reported SMA type, n (%)
 Type 2 61 (73) 76 (92)
 Type 3 23 (27) 7 (8)
Motor function, n (%)
 Cannot sit 5 (6) 0 (0)
 Can sit with some support 36 (43) 3 (4)
 Cannot sit independently for few seconds 16 (19) 0 (0)
 Can sit independently for longer 18 (21) 67 (81)
 Can stand with assistance 6 (7) 13 (16)
 Can walk with assistance 3 (4) 0 (0)
 Can walk independently for a few steps 0 (0) 0 (0)
Breathing function, n (%)
 Mechanical support >16 h/day 1 (1) 0 (0)
 Mechanical support for some of the day 22 (26) 43 (52)
 No mechanical support 61 (73) 40 (48)
SMA treatment, n (%)
 Nusinersen (SPINRAZA®) 1 (1) 54 (65)
 Surgery 17 (20) 2 (2)
 Other 13 (15) 1 (1)
 None 58 (69) 29 (34)
Tools/equipment, n (%)
 Breathing machine/mechanical. ventilation 30 (36) 45 (54)
 Feeding tube 9 (11) 0 (0)
 Suction machine to help clear throat 10 (12) 79 (95)
 Walking frame 1 (1) 39 (47)
 Wheelchair 84 (100) 81 (98)
 Other 22 (26) 1 (1)
Comorbidities (multicode), n (%)
 Any 19 (22) 0 (0)
 Musculoskeletal comorbidities 10 (12)
 Other comorbidities 12 (14)
Caregiver EQ-5D-5L, mean (SD)
Can sit with some support (n = 3) 0.862 (0.127)
Can sit independently for longer (n = 67) 0.939 (0.092)
Can stand with assistance (n = 13) 0.964 (0.074)

SMA spinal muscular atrophy